Are GLP-1 drugs making surgery riskier? new study investigates
NCT ID NCT07251803
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether people taking GLP-1 or GIP medications (like Ozempic or Mounjaro) have more food left in their stomach after standard fasting before surgery. Researchers will use ultrasound to measure stomach volume in 150 adults who either fasted for 8 hours or had a clear liquid diet for 24 hours. The goal is to see if the usual fasting rules are enough to keep these patients safe during procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help clarify whether current fasting guidelines are adequate for patients taking GLP-1 drugs before surgery, potentially improving safety.
- What could go wrong
- This is an observational study, not a treatment trial. It only measures stomach volume, not actual complications, so results may not directly change practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC RETENTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical University of South Carolina
RECRUITINGCharleston, South Carolina, 29425, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.